As a transcription factor, localization to the nucleus and the recruitment of cofactors to regulate gene transcription is essential. Nuclear localization and nucleosome remodeling and histone deacetylase (NuRD) complex binding are required for the zinc-finger transcription factor CASZ1 to function as a neuroblastoma (NB) tumor suppressor. However, the critical amino acids (AAs) that are required for CASZ1 interaction with NuRD complex and the regulation of CASZ1 subcellular localization have not been characterized. Through alanine scanning, immunofluorescence cell staining and co-immunoprecipitation, we define a critical region at the CASZ1 N terminus (AAs 23-40) that mediates the CASZ1b nuclear localization and NuRD interaction. Furthermore, we identified a nuclear export signal (NES) at the N terminus (AAs 176-192) that contributes to CASZ1 nuclear-cytoplasmic shuttling in a chromosomal maintenance 1-dependent manner. An analysis of CASZ1 protein expression in a primary NB tissue microarray shows that high nuclear CASZ1 staining is detected in tumor samples from NB patients with good prognosis. In contrast, cytoplasmic-restricted CASZ1 staining or low nuclear CASZ1 staining is found in tumor samples from patients with poor prognosis. These findings provide insight into mechanisms by which CASZ1 regulates transcription, and suggests that regulation of CASZ1 subcellular localization may impact its function in normal development and pathologic conditions such as NB tumorigenesis.
INTRODUCTION
CASZ1 is a transcription factor that has a central role in neural and cardiac developmental programs and has been increasingly implicated in pathologic conditions including cancer. [1] [2] [3] [4] [5] [6] [7] [8] [9] In humans, CASZ1 localizes to chromosome band 1p36, and loss of heterozygosity of this region is implicated in many types of cancers. 6 A clinical case report showed that CASZ1 gene expression was disrupted as a consequence of human papillomavirus DNA integration into the CASZ1 gene locus in a case of cervical cancer. 10 In colorectal cancer, CASZ1 and MASP2 fusion transcript was detected, and this fusion product encodes an N-terminal-truncated MASP2, which is under the control of CASZ1 promoter. 11 Our studies have shown that the CASZ1 gene is silenced in poor prognosis neuroblastoma (NB) patient tumor samples through the loss of heterozygosity and/or EZH2-mediated epigenetic silencing. 12 The human CASZ1 gene encodes two major isoforms: isoform CASZ1a, with 1759 amino acids (AAs) with 11 TFIIIA class C2H2 zinc (Zn)-fingers, and the more evolutionarily conserved isoform CASZ1b, with 1166 AAs that are identical to CASZ1a but lacks the last 6 Zn-fingers; we found that both of them suppress NB tumor growth. 7, [13] [14] [15] With next-generation sequencing approaches and the emerging sequence variations in the human genome, structure and function analyses of CASZ1 are critical for the ultimate understanding of benign or pathologic alterations in the CASZ1 tumor suppressor gene. In recent studies, we identified multiple critical regions that are important for CASZ1 transcriptional activity, and found that CASZ1 interacts with the NuRD complex and the deletion of AAs 31-185 disrupts this interaction. 15, 16 However, the critical AAs that mediate NuRD binding and are required for transcriptional activity have not been analyzed in detail. Moreover, nuclear-cytoplasmic shuttling of classic tumor suppressors such as BRCA1, p53 and Rb during tumor progression results in changes in their tumor suppressor capability. This phenomenon highlights the importance of identifying critical regions that mediate CASZ1 subcellular localization and investigating the subcellular localization of CASZ1 in patients with NB tumors.
In this report, we map the nuclear localization signal 1 (NLS1) of the evolutionarily conserved CASZ1b isoform to AAs 23-40, and identify the critical AAs in NLS1 that are essential for CASZ1b transcriptional activity and NuRD complex binding. Moreover, we identified a novel CRM1-(chromosome region maintenance 1, also called XPO1, exportin 1) dependent nuclear export signal (NES) at the N terminus of CASZ1b. Importantly, we find that localization of CASZ1 in the cytoplasm is associated with poor prognosis in NB patients. The identification of AAs mediating CASZ1 localization provides insights into the molecular mechanisms regulating CASZ1 function in normal development and human disease.
RESULTS

N terminus of CASZ1b mediates its transcriptional activity and subcellular localization
CASZ1b is the more evolutionarily conserved isoform of the CASZ1 gene. 14 In a previous report, we identified the N terminus of CASZ1b (AAs 31-185) to be critical for the regulation of gene transcription and NuRD complex binding. 15, 16 However, we did not have single AA resolution to show which AAs were critical for CASZ1b transcriptional activity and NuRD complex binding. To refine our understanding of the transcription regulation domain as well as to assess whether other domains in CASZ1 have a role in the regulation of its subcellular localization, we made additional variant N-terminal deletion constructs in an N-terminal FLAG- 1 tagged CASZ1b (Figure 1a ). To investigate the transcriptional activity of these CASZ1b mutants, 293T cells that have low endogenous CASZ1 expression were transfected. We used a tyrosine hydroxylase luciferase (TH-Luc) reporter assay, as we know that TH is transcriptionally regulated by CASZ1. 15 We found that the deletion of AAs 1-168, 1-185, 1-223 or 1-448 leads to a significant decrease in the transcriptional activity of wild-type (WT) CASZ1b based on the TH-Luc reporter assay ( Figure 1b ).
To assess whether the loss of transcriptional activity is due to a change in its subcellular localization, FLAG-CASZ1b mutants transfected into 293T cells were stained with an anti-FLAG antibody (Figure 1c ). In 293T cells transfected with WT CASZ1b, the cells have nuclear staining (Figure 1c ). In 293T cells transfected with CASZ1bΔN168 (deletion of AAs 1-168), CASZ1 predominantly localizes to the cytoplasm (Figure 1c ), which is not surprising as the NLS1 (AAs 23-29) is lost. However, deletion of an additional 18
AAs in CASZ1bΔN186 resulted in a nuclear localization, presumably using NLS2. This suggests that an NES in AAs 168-186 may be responsible for the cytosolic localization of CASZ1bΔN168, which counteracts the NLS2 signal. The CASZ1bΔN448, which loses both NLS1 (AAs 23-29) and NLS2 (AAs 232-248), localizes only in the cytoplasm (Figure 1c ). The finding that CASZ1bΔN186 transcriptional activity is significantly decreased (Figure 1b ), even though it predominantly localizes to the nucleus (Figure 1c ), indicates that this region contains transcriptional regulation domain.
To further define the critical regions required for the transcriptional activity of CASZ1b without disrupting nuclear localization, we made a series of CASZ1b deletions between NLS1 and NLS2 within the AAs 31-185 region ( Figure 1d ) and transfected these constructs into 293T cells. Deletion of AAs 101-185 resulted in the retention of nuclear localization and transcriptional activity, indicating that this region is not required for CASZ1b transcriptional activity ( Figure 1e ). activity of CASZ1b N-terminus deletions using TH-Luc reporter (data are shown as means ± s.e.m., *Po0.001, compared with WT CASZ1b); right panel: western blot showing steady-state levels of WT, Δ168, Δ186, Δ223 and Δ448 of CASZ1b protein levels 24 h after transfection into 293T cells. (c) Assessment of cellular localization of CASZ1b and N-terminus deletion proteins. FLAG-tagged CASZ1b WT and N-terminus deletion plasmids were transfected into 293T cells and stained with anti-FLAG antibody and DAPI (4',6-diamidino-2-phenylindole) 24 h after. (d) Schematic of CASZ1b WT and mutant proteins with deletion between NLS1 and NLS2. (e) Top panel: Activation of the TH-Luc construct 24 h after transfection of 293T cells by CASZ1b WT, Δ31-100, Δ101-185 and Δ31-46 (data are shown as means ± s.e.m., *P o0.001, compared with WT CASZ1b); bottom panel: western blot showing steady-state levels of WT, Δ31-100, Δ101-185 and Δ31-46 of CASZ1b proteins 24 h after transfection into 293T cells. (f) Real-time PCR to determine CASZ1b mutants transcriptional activity at regulating endogenous TH, NGFR and NTRK1 mRNA transcription, the variants with nucleus localization marked with (+) under the graph (data are shown as means ± s.e.m., *P o0.005, compared with WT CASZ1b). (g) Assessment of cellular localization of CASZ1b variants. Cells transfected with FLAG-tagged CASZ1b N-terminus deletion constructs were stained with an anti-FLAG antibody and DAPI. (Figure 1f ). This suggests that although the previously defined NLS1 (AAs 23-29) can have a role as nuclear localization signal, 15 additional AAs after AAs 23-29 are also critical for proper nuclear retention of CASZ1b.
Alanine scanning to define transcriptional domain and NuRD binding sites Deletion of AAs 31-46 led to CASZ1b cytoplasmic localization, which hindered assessment of the critical AAs required for NuRD complex binding and transcriptional activity of CASZ1b. In CASZ1, AAs 23-43 are evolutionarily conserved (Figure 2a ), thus we used an alanine scanning mutation approach in this region to define AAs critical for NuRD binding and transcriptional activity ( Figure 2b ). These FLAG-CASZ1b mutants were transiently transfected into 293T cells and stained using anti-FLAG antibody. CASZ1b R25AK26A, I34A, K37A, L38A and R40A mutants localize to the cytoplasm, whereas G27AG28A, L29AK30A, L31A, N32A, C35A, S39 and Q41AV42A mainly localize to the nucleus (Figure 2c ). To confirm the subcellular localization of CASZ1b mutants detected through immunofluorescence staining, we also created CASZ1b mutant-EGFP fusion constructs and transfected them into 293T cells and NB SK-N-AS (AS) cells. AS cells have loss of heterozygosity on chromosome 1p and the endogenous CASZ1 level is low. Consistent with immunofluorescence staining, the CASZ1-L31A-EGFP and CASZ1N32A-EGFP localize to the nucleus, whereas the CASZ1-K37A-EGFP localize to the cytoplasm in both of the 293T and AS cell lines ( Figure 2d ). These results indicate that the region encompassing AAs 23-40 is important for CASZ1b nuclear localization.
To determine the transcriptional activity of CASZ1b mutants, TH-Luc reporter assay was performed. Results showed that the transcriptional activity of CASZ1b R25AK26A, -I34A, -K37A, -L38A and -R40A mutants was significantly decreased compared with WT CASZ1b (Figure 3a ). These results correlated well with their cytoplasmic localization. CASZ1b-G27AG28A, -L29AK30A, -C35A, -S39 and -Q41AV42A mutants localized to the nucleus but retained the transcriptional activity ( Figure 3a ). However, even though CASZ1b-L31A and -N32A mutants localized to the nucleus, their transcriptional activity was impaired. L31A had an~40% decreased transcriptional activity compared with CASZ1b ( Figure 3a ). Consistently, real-time PCR results showed that the nuclear-localized mutants L31A and cytoplasmic-localized K37A also significantly decreased CASZ1b activity in regulating endogenous TH, NGFR and NTRK1 transcription ( Figure 3b ). N32A mutant had only an~25% decreased transcriptional activity at regulating TH-Luc reporter as well as endogenous TH, but had subtle effect on endogenous NGFR and no effect on endogenous NTRK1. This indicates that at the AA 23-40 region, L31 is the most critical AA for CASZ1b transcriptional activity, which does not impact the regulation of subcellular localization.
Previously, we have shown that CASZ1 transcriptional activity is dependent on NuRD binding. 16 To determine whether the Transcription regulation domain and NES in CASZ1 Z Liu et al decrease of the transcriptional activity of CASZ1b-L31A is associated with NuRD complex binding ability, empty vector, CASZ1b-L31A, -N32A and -Q41V42A constructs were transfected into 293T cells, and co-immunoprecipitation (co-IP) was performed. We found that while CASZ1b pulled down NuRD subunits, only the L31A mutant completely loses the ability to pull down NuRD subunits such as MTA2, MTA3, HDAC1, RBAP46/48 and MBD3 ( Figure 4 ). The disruption of the interaction between CASZ1b mutant L31A and NuRD subunits was specific as L31A retained its interaction with PARP1 and histone H3 ( Figure 4 ); this is expected as CASZ1b interacts with PARP1 and histone H3 through a PAR binding motif in the Zn-finger region of CASZ1b protein. 16 CASZ1b regulates genes that are important for cell growth and developmental processes in NB As the transcriptome regulated by CASZ1b isoform has not been investigated in NB to date, we evaluated the global transcriptome regulated by CASZ1b to gain insight into potential targets and mechanisms of action. We used Agilent whole human genome oligo microarray analyses (G4112F; Agilent, Santa Clara, CA, USA) to investigate the genome-wide transcriptional consequences of expression of CASZ1b in NB cells (SY5YtetCASZ1b) in which CASZ1b gene expression is regulated by tetracycline (Tet). After Tet induction for 24 h (Tet+), 483 genes were commonly regulated by CASZ1b in SY5YtetCASZ1b, three replicates (Supplementary Table 1 , increased/decreased 42-fold, P o 0.05). Among those regulated genes, clusterin and NGFR also have NB tumor suppressor activity. 17, 18 Molecular and cellular function assay of these 483 differently expressed genes using Ingenuity Pathways Analysis (IPA) tool indicated that the top 5 classes of the altered genes involved in cell growth and proliferation, cellular movement, cellular development and cell morphology, as well as cell death and survival ( Figure 5A and Supplementary Table 2 ). Physiological system development and function assay using IPA tool showed that genes involved in the nervous system and cardiovasculature development were significantly enriched in the genes regulated by CASZ1b (data not shown). To further gain insights from the microarray data, we performed gene set enrich analysis (GSEA) 19, 20 using the whole microarray gene list (Tet+ vs Tet − ). GSEA is able to determine whether an a priori defined set of genes shows a statistically significant difference between CASZ1b-induced and control SY5Y cells (Tet+ vs Tet − ). The results showed that the 'neurological_system_process' genes (genes involved in the process pertaining to the functions of the nervous system of an organism) were positively enriched in CASZ1b-overexpressed cells ( Figure 5B , left panel; Supplementary Table 3 ). Moreover, the 'hallmark_MYC_-targets_v2' genes (a subgroup of genes regulated by MYC) were negatively enriched in CASZ1b-overexpressed cells ( Figure 5B , right panel; Supplementary Table 4 ). Similarly, the 'hallmark_MYC_tar-gets_v1' genes (another subgroup of genes regulated by MYC) were also negatively enriched in CASZ1b-overexpressed cells (data not shown). These results are consistent with CASZ1 being a neural fatedetermination gene and tumor suppressor.
To investigate whether cytoplasmic sequester or loss of NuRD complex binding affects CASZ1b transcriptional activity in NB cells, we generated SY5YtetCASZ1b K37A-and SY5YtetCASZ1b L31Astable cell lines and investigated the transcriptional activity of CASZ1b-L31A and -K37A at regulating genes, identified using the microarray analysis. Consistent with the microarray data, we found that the induction of CASZ1b by Tet significantly upregulated TH, NGFR and CD9, and significantly downregulated MYC and KIT expression ( Figure 5C ). The gene expression changes were not due to Tet treatment as their expression did not change when SY5YtetEV cells were treated with Tet ( Figure 5C ). We found that the cytoplasmically localized K37A mutant almost completely lost the transcriptional activity at regulating all the tested endogenous genes that have been regulated by WT CASZ1b in SY5Y cells, which include TH, NGFR, CD9, MYC and KIT ( Figure 5C ). The L31 mutant that fails to bind NuRD complex was partially defective at regulating TH, NGFR and MYC transcription compared with WT CASZ1b, but did not decrease the transcriptional activity at regulating CD9 and KIT, instead there was a slight increase at regulating CD9 compared with WT CASZ1b ( Figure 5C ). This result indicates that cytoplasm retention of CASZ1b in NB cells disrupt its downstream transcriptional pathways. Additionally, the failure of CASZ1b to recruit NuRD complex may partially affect its ability to regulate a subset of CASZ1b target genes.
Identification of NES in CASZ1b
The CASZ1bΔN168 whose deletion encompasses NLS1 (Figures 1a and c) has a cytosolic localization despite the retention of NLS2 (AAs 232-247). However, the loss of an additional 18 AAs in the CASZ1bΔN186 mutant enables CASZ1 nuclear localization (Figures 1a and c) . These findings suggest the existence of a putative NES around the AA 168-86 region, which functions to export CASZ1 when the NLS1 is deleted, but when the putative NES is lost or disrupted (CASZ1bΔN186), it allows NLS2 to function to retain the truncated CASZ1b in the nucleus. To test this hypothesis, we performed in silico bioinformatics analysis (http:// wregex.ehubio.es/) of CASZ1b using Wregex (weighted regular expression) 1.1 program that has been developed for motif scanning. 21 It revealed a CRM1-dependent NES motif in CASZ1b (AAs 176-192) ( Figure 6a ). Hydrophobic AAs are critical for NES activity. 22, 23 Of the 17 AAs in this region, 5 AAs are hydrophobic and they are all evolutionarily conserved between CASZ1 homologs in human and zebrafish (Figure 6a , hydrophobic AAs are underlined in red).
We hypothesized that in CASZ1b the putative NES can compete with NLS2. When the NES is intact (as in CASZ1bΔ168), it may over-ride the NLS2 nuclear localization signal, thus CASZ1bΔ168 stays in the cytoplasm. When the NES is disrupted (as in CASZ1bΔ186), only NLS2 has a role, thus CASZ1bΔ186 has a nuclear location. To test this hypothesis, we generated NLS2 (AAs 232-247) or NES-NLS2 (AAs 171-250) GFP fusion proteins (Figures 6a and b ). NLS2-GFP contains the NLS2 of CASZ1b, and NES-NLS2-GFP contains both the putative NES and the NLS2 of CASZ1b. To investigate the subcellular localization of these constructs, we transfected the NLS2-GFP or NES-NLS2-GFP Figure 4 . NLS1L31 is critical for NuRD complex binding. Co-IP of FLAG-CASZ1b and mutant construct-transfected 293T cells using anti-FLAG antibody, and the blot were probed with anti-FLAG, PARP1, MTA2, HDAC1, RBAP46/48, MBD3 and histone H3 antibody.
plasmids into 293T cells (Figure 6c ). In over 90% of the transfected cells, NLS2-GFP localized exclusively to the nucleus. In contrast, o 20% of cells transfected with the NES-NLS2-GFP localized solely to the nucleus, which is significantly lower than NLS2-GFP ( Figure 6c , right panel, black columns, P o 0.001). This is consistent with the putative NES having a nuclear export function. We further mutated the putative NES in the NES-NLS2-GFP construct by replacing the conserved hydrophobic AAs with alanine ( Figure 6b ) and named this construct as NESm-NLS2-GFP. In contrast to NES-NLS2-GFP, NESm-NLS2-GFP mainly localizes to the nucleus in over 60% of the transfected 293T cells, which is significantly higher than NES-NLS2-GFP (Figure 6c , right panel, black Compared with WT CASZ1b, K37 almost completely lost transcriptional activity at regulating all these genes in SY5Y cells (data are shown as means ± s.e.m., *P o0.05). Compared with WT CASZ1b, L37 significantly decreased the transcriptional activity at regulating TH, NGFR and MYC, but had a slight increase at regulating CD9 and no effect on KIT (data are shown as means ± s.e.m., *P o0.05).
columns, Po0.001). Similar results were found when NES-NLS2-GFP and its mutant were transfected into the NB AS cell line (Figure 6d ). We also generated NES-EGFP and NESm-EGFP constructs. We found that EGFP alone has a more nuclear localization, perhaps due to diffusion; 24 however, the GFP signal in NES-EGFP-transfected cells is more evenly distributed between the cytoplasm and nucleus. When the NES is mutated, there are more cells with a stronger nuclear GFP signal ( Supplementary Figure 1) . Our results are consistent with this NES region having a nuclear export role in this reporter system.
Most of the identified NESs regulate protein nuclear export in a CRM1-dependent manner. Leptomycin B (LMB) treatment can inactivate CRM1 through covalent modification at a cysteine residue of CRM1. 23, 25, 26 To determine whether the NES in CASZ1b is CRM1-dependent, we used the CASZ1bΔN168 construct as it contains the NES and NLS2 (Figure 7a ), and it localizes to the cytoplasm in 293T cells. FLAG-CASZ1bΔN168-transfected 293T cells were treated with 20 ng/ml LMB for 3.5 h, fixed and stained with anti-FLAG antibody (Figure 7b ). In untreated cells,~10% of the cells contained solely nuclear CASZ1bΔN168. In contrast, in LMB-treated cells there was an almost fivefold increase in cells with nuclear CASZ1bΔN168 compared with controls ( Figure 7c , black columns, Po0.005).
The subcellular localization of CASZ1 differs in a tissue-dependent manner The existence of NLS and NES in CASZ1 indicates that the nuclearcytoplasmic shuttling of the CASZ1 protein may occur during Figure 6 . CASZ1b contains NES at the N terminus. (a) The alignment of human CASZ1 (hcas) and zebrafish CASZ1 (zcas) at the N-terminal region that contains a putative NES with five conserved hydrophobic AAs (underlined in red) between AA175 to AA191. (b) The NES-NLS2-GFP and NES mutant-NLS2-GFP constructs. CASZ1b AAs 170-249 region that contains both putative NES and NLS2 was fused to GFP. NESm-NLS2-GFP is an NES mutant constructed by replacing the five conservative hydrophobic AAs within putative NES and one hydrophobic AA close to NES with alanine (highlighted in red). (c) The 293T cells and (d) AS cells were transiently transfected with NLS2-GFP, NES-NLS2-GFP and NESm-NLS2-GFP constructs, and chromatin was stained with DAPI (4',6-diamidino-2-phenylindole) . A minimum of 300 cells were screened for each group from at least three different fields and scored for nuclear and cytoplasmic (Nuc & Cyt) or nuclear-only (Nuc) staining (data are shown as means ± s.d., *P o0.001). None of the cells have cytoplasmic-only GFP signal, and thus Cyt was not shown in the graph.
normal development and this shuttling may regulate CASZ1 function. To investigate the subcellular localization of CASZ1 in different cell or tissue types, an antibody specific for human and murine CASZ1 was used, and this antibody recognizes the common epitope on both CASZ1a and CASZ1b isoforms. The anti-CASZ1 antibody was first used to stain SK-N-BE2 NB cells, which have high endogenous CASZ1 expression, and we found that CASZ1 was predominantly expressed in the nucleus (Figure 8a, top panel) . Prior incubation of the anti-CASZ1 antibody with the immunizing peptide that was used to generate CASZ1 antibody completely blocked CASZ1 immunoreactivity in SK-N-BE2 cells (Figure 8a , bottom panel). To test whether anti-CASZ1 antibody can be used on formalin-fixed tumor tissue, NGPtetCASZ1a xenograft tumor samples were incubated with anti-CASZ1 antibody. NGPtetCASZ1a is a cell model in which CASZ1a expression can be induced by Tet. Staining results showed that specific CASZ1 immunoreactivity is detected in NGPtetCASZ1a tumor xenograft from a Tet-treated mouse (Figure 8b, top) , but not in the NGPtetCASZ1a tumor xenograft from a control-treated mouse (Figure 8b, bottom) . These studies indicate that the anti-CASZ1 antibody is specific and can be used on a formalin-fixed tissue.
We next investigated subcellular localization of CASZ1 in normal murine ocular tissue as CASZ1 is highly expressed in this tissue at both the mRNA and protein level. 14, 27 By staining adult murine ocular tissue sections for CASZ1, we found that CASZ1 localizes to the nucleus in lens epithelia but localizes primarily to the cytoplasm in photoreceptor cells (Figure 8c ). This is consistent with the finding that CASZ1 localizes to the cytoplasm of photoreceptor cells during retinogenesis. 8 The findings of distinct nuclear and cytoplasmic localization of CASZ1 in different ocular tissues suggest that the subcellular localization of CASZ1 may have a role in mediating its functional activity during normal development.
Expression and subcellular localization of CASZ1 protein in NB patients' tumor samples
Although we have previously reported that high levels of CASZ1 mRNA are found in primary NB tumors from patients who have good prognosis, 7,14 the expression of CASZ1 protein in primary NB tumor tissue has never been assessed. To determine the association of CASZ1 protein levels and NB patients' risk factors, we stained a tissue microarray (TMA) containing primary NB tumor samples with an anti-CASZ1 antibody. The TMA contained duplicate cores for each sample, and only those samples with consistent results in the duplicates were used for data analysis. Among the 112 evaluable patient tumor samples, 94 samples (84%) were found to have detectable CASZ1 expression. CASZ1 protein localized to the nucleus in 80% of the 94 samples, while in 10% of the tumor samples, CASZ1 localized to both the nucleus and cytoplasm. In the remaining 10%, CASZ1 localized only to the cytoplasm of the tumor cells. Representative images of cytoplasmic-only and nuclear plus cytoplasmic staining patterns of CASZ1 are shown in Figure 9A .
We next evaluated the association of nuclear CASZ1 protein expression with the prognostic factors of NB patients. Representative images are shown in Figure 9B for the four scoring categories of CASZ1 immunoreactivity detected in the TMA: (1) score 0: negative, no reactivity to o 1% positive nuclei;
(2) score 1: 1-10% positive nuclei; (3) score 2: 10-50% positive nuclei; (4) score 3: strong positive, 450% positive nuclei, respectively. Using 10% positive nuclear staining as a cutoff, χ 2 analysis showed that the samples scoring 0 and 1 with low nuclear CASZ1 expression are associated with MYCN amplification, unfavorable Shimada histology and high risk ( Table 1 , all P o 0.05; chromosome 1p status not available for this archival case series). Amplification of the MYCN gene (45 copies) or unfavorable Shimada histology (a histopathological classification system) are molecular and histologic parameters that are found in high-risk NB patients. [28] [29] [30] Among the 27 tumor samples scoring 0, nine samples (33%) had CASZ1 expression, with the protein localizing only to the cytoplasm. Interestingly for the samples with CASZ1 restricted to the cytoplasm, 90% (7/8 samples) of the ones with available information on Shimada pathology showed unfavorable Shimada histology. This contrasts with the tumors that had strong nuclear CASZ1 staining, scoring 2 and 3, in which 57% (38/67) showed significant favorable Shimada histology (Tables 1, P = 0.044). Although the sample size is small, these data are consistent with a model in which the retention of CASZ1 in the cytosol may contribute to loss of CASZ1 function in the tumors of some NB patients who have poor prognosis.
DISCUSSION
The transcriptional activity of transcription factors is modulated by their subcellular localization and the cofactors they recruit. In this study, we defined AAs 23-40 in CASZ1b as critical for nuclear localization as well as NuRD complex interaction and regulation of gene transcription. We also identified and functionally characterized a CRM1-dependent NES domain at the N terminus of CASZ1b that may be relevant to its subcellular localization in different cell types. Moreover, we found that high nuclear expression of CASZ1 in NB tumors is associated with good prognostic features, whereas tumors with cytoplasmic localization of CASZ1 are more frequently found in NB patients with poor prognosis.
Nuclear-cytoplasmic shuttling of transcription factors is an important way to control their activity in response to stress or extracellular environmental signals and this is regulated through NES and NLS. Through four approaches including (1) bioinformatic in silico assay of CASZ1b (Figure 6a ), (2) NES-NLS2-GFP subcellular localization study (Figure 6c ), (3) CASZ1bΔ168/CASZ1bΔ186 subcellular localization study ( Figure 1c ) and (4) CASZ1bΔ168 subcellular study with or without CRM1 inhibitor treatment (Figure 7) , we demonstrate that there is an NES signal within AAs 168-192 in the CASZ1 protein. The existence of both NLS and NES may provide a rapid mechanism to regulate CASZ1 transcriptional activity during development. Normal tissue staining revealed that CASZ1 could localize either to the nucleus or the cytoplasm (Figure 8) , indicating that CASZ1 subcellular localization is regulatable in normal tissues. In fact, many critical cell fate-determination transcription factors are tightly regulated by multiple NLS and NES motifs including SOX protein and T-box protein. [31] [32] [33] For example, the SOX proteins contain both NLS and NES that are regulated by a nuclear export mechanism during murine embryonic development. 33 Transcription factors with tumor suppressor activity such as BRAC1, p53 and RB also have both NLS and NES and can be shuttled between the nucleus and cytoplasm under stress or during tumor progression, resulting in changes in their transcriptional activity and tumor suppressor capability. [34] [35] [36] [37] [38] [39] The p53 protein has two NESs and three NLSs: 38, 40, 41 the N-terminal NES is regulated by phosphorylation events in response to DNA damage, 40 and the NES in the tetramerization domain is masked upon p53 oligomerization. 38 An area of future investigations is an assessment of which signal-transduction pathways regulate CASZ1 nuclear-cytoplasmic localization.
Previously, we have found that low levels of CASZ1 mRNA are found in NB tumors that have a poor prognosis and high levels are found in those that have a better prognosis. 7, 14 The TMA study shows that tumors enriched in nuclear CASZ1 are from patients who have a low risk and medium risk or favorable Shimada histology. Yet, in 10% of CASZ1-positive tumor samples, the CASZ1 protein was completely localized to the cytoplasm, and these tumors have unfavorable Shimada histology in patients with poor prognosis. We have shown that when CASZ1b localizes to the cytoplasm, it markedly decreases its ability to suppress NB cell growth. 15 In this study, the transcriptome analysis of CASZ1b in NB indicates that CASZ1b regulates genes involved in cell growth and Figure 5A) , and GSEA showed that CASZ1b represses MYC target genes ( Figure 5B) , which supports CASZ1b function as a tumor suppressor. Importantly, the cytoplasmic-localized mutant K37A almost completely lost the ability to regulate the transcription of all the tested CASZ1b target genes in NB cells, indicating that the decreased nuclear accumulation of CASZ1 disrupts its downstream transcriptional program. Thus, under certain conditions, the shuttling of CASZ1 from the nucleus to the cytoplasm decreases its transcriptional activity and consequently impairs its tumor-suppressing function. This functional loss of CASZ1 transcriptional activity may contribute to tumor progression. CRM1-dependent cytosolic localization has been shown to functionally reduce the activity of cancer-related proteins such as p53, Rb, APC, c-Abl and FOXO-3A. For this reason, a number of nuclear export inhibitors have been developed and some show antitumor activity in different mouse tumor xenograft models, and are in early phase clinical testing. [42] [43] [44] [45] [46] [47] Whether this is a mechanism relevant for CASZ1 remains an area of future investigation.
The CASZ1 NES is not required for its transcriptional activity as CASZ1bΔN101-185, which has disrupted the NES, has the same transcription activity as WT CASZ1b (Figures 1d-f ). However, our data reveal that the redefined NLS1 is required for its nuclear localization as well as its transcriptional activity. Consistently, Figure 9 . CASZ1 is differentially expressed in NB patients' tumor samples and may localize to the nucleus, the cytoplasm or both. (A, a) CASZ1 localized exclusively in the cytoplasm showed by staining the tumor samples with anti-CASZ1 antibody; b, CASZ1 localized to both the nucleus and the cytoplasm. Nucleus was counterstained with hematoxylin solution showed in blue, and CASZ1 was probed with rabbit anti-CASZ1 antibody and shown in brown. (B) Examples of nuclear staining: a, score 0-a rare positive nuclei; b, score 1 (1-10% positive) equivocal/uninterpretable; c, score 2 (10-50%) weak positive; or d, score 3 (450% positive cells) strong positive.
co-IP results demonstrate that CASZ1b recruits NuRD complex through this NLS1 region to regulate gene transcription (Figure 4) . The L31A mutant disrupts CASZ1 interaction with NuRD complex decreasing its transcriptional activity, supporting our model in which NuRD mediates CASZ1b transcriptional activity. 16 We observed that CASZ1b-L31A fails to bind the NuRD complex but only partially decreased the transcriptional activity. NuRD has been reported to remodel chromatin to regulate gene transcription, or interact with p-TEFb to facilitate transcription elongation. 48, 49 As a cofactor, NuRD complex can either enhance or decrease basal gene transcription regulation of a transcription factor, thus although CASZ1b-L31A fails to bind NuRD, it may still retain the ability to regulate basal gene transcription via interacting with other cofactors and transcriptional machinery. In fact, we observed that CASZ1b-L31A retains PARP1 binding (Figure 4) , a DNA repair protein that has been reported to regulate the chromatin structure and gene transcription. 50 In summary, we have identified and characterized critical AAs that regulate CASZ1 nuclear-cytoplasmic localization and cofactor interactions that modulate its transcriptional activity. Nuclearcytoplasmic shuttling would be an important way to regulate the CASZ1 gene regulatory network during normal development and its disruption may contribute to pathological conditions.
MATERIALS AND METHODS
Cell culture
Human embryonic kidney 293T cells were obtained from ATCC (Manassas, VA, USA), and were maintained in Dulbecco's modified Eagle's media. NB SK-N-AS and SK-N-BE2 cell lines were maintained in RPMI-1640 media. All the cell culture medium was supplemented with 10% fetal calf serum as well as 100 μg/ml streptomycin, 100 U/ml penicillin and L-glutamine. Cells were grown at 37°C with 5% CO 2 . NB NGPtetCASZ1 cells are NGP cells that were stably transfected with CASZ1a and its expression is Tet-inducible. 7 The cell lines used have been authenticated and are mycoplasma free.
Construction of missense, deletion and fusion CASZ1b constructs and NES-NLS-GFP constructs
To make the NES-NLS2-GFP construct, the NES-NLS2 fragment of CASZ1b (AAs 171-250) was generated by PCR amplification before cloning, the primer used was synthesized with an attached 5′ EcoRI site and a 3′ BamHI site and was cloned into the corresponding sites of pmaxFP-Green-N vector (Lonza, Walkersville, MD, USA). To make the NES-EGFP construct, the NES fragment of CASZ1b (AAs 171-210) was generated by PCR amplification before cloning, the primer used was synthesized with an attached 5′ EcoRI site and a 3′ BamHI site and was cloned into the corresponding sites of pEGFP-N3. To make the CASZ1b-EGFP constructs, full length of CASZ1b was generated by PCR, and the primer used was synthesized with an attached 5′ EcoRI site and a 3′ BamHI site and was cloned into the corresponding sites of pEGFP-N3. The QuikChange XL Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA, USA) was used to introduce various missense mutations into the WT FLAG-CASZ1b plasmid, 13 NES-EGFP or the NES-NLS2-GFP construct as per the manufacturer's protocol. To generate CASZ1b-EGFP mutant constructs, the FLAG-CASZ1b mutants were subcloned into CASZ1b-EGFP through SbfI and PshAI enzyme digestion.
Luciferase assay
Plasmids were transiently transfected into human embryonic kidney 293T cells using the Lipofectamine 2000 cationic lipid reagent (Thermo Scientific, Walkersville, MD, USA) according to the manufacturer's protocol. In luciferase experiments, the TH promoter-pGL4.1-Luc construct (TH-Luc), which contains the proximal 2 kb of the TH promoter, was generously provided by Dr Gregory Wray. 51 A cytomegalovirus-driven β-galactosidase construct was co-transfected with TH-Luc and different CASZ1b mutants to provide an internal control for transfection efficiency. Luciferase activity was quantified after 24 h using the Luciferase Reporter Assay System (Promega, Madison, WI, USA), and β-galactosidase activity was measured concomitantly with the Luminescent β-galactosidase Detection Kit II (Clontech, Mountain View, CA, USA) to normalize the luciferase signals.
Real-time PCR
Total mRNA was collected 24 h after transfection using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA) as per the manufacturer's protocol. Endogenous transcription of known CASZ1 target gene TH, NGFR and NTRK1, 7 and some other newly identified CASZ1b target genes from this study were used to assess transcriptional activity of CASZ1b variants. Quantitative measurements of total β-actin and target gene levels were obtained using the BIO-RAD CFX Touch Real-Time PCR detection system (Hercules, CA, USA) and performed in triplicate. Ct values were standardized to β-actin levels, and the fold change in mRNA was calculated compared to the empty vector-transfected control samples.
Stable clones
The NB stable clone was made as reported previously. 15 In brief, WT CASZ1b, the CASZ1b-L31A mutant and the CASZ1b mutant K37A cloned in pT-Rex-DEST30 were transfected into SH-SY5Ytet (SY5Ytet) cells that had been previously stably cloned with pcDNA6/TR. The transfected cells were cultured in selective medium containing both blasticidin S and G418. After selection, individual colonies were selected and treated with Tet to induce CASZ1b transcription. Stable clones expressing CASZ1b or CASZ1 mutations are labeled as SY5YtetCASZ1b, SY5YtetCASZ1b L31A (L31A) and SY5YtetCASZ1b K37A (K37A). The stable clone with empty vector are labeled as SY5YtetEV. Pilot experiment results indicated that the protein levels of WT CASZ1b and mutant CASZ1b stay the same when SY5YtetCASZ1b cells have been treated with 3.3 ng/ml Tet and L31A or K37A cells have been treated with 1 μg/ml Tet. Thus, when compared with the transcriptional activity of WT CASZ1b and mutant CASZ1b in SY5Y cells, 3.3 ng/ml Tet was used for SY5YtetCASZ1b cells and 1 μg/ml Tet was used for SY5YtetEV, L31A and K37A cells. Otherwise, the stable clones will be treated with 1 μg/ml Tet to induce CASZ1b expression. The cells used have been authenticated and are mycoplasma free.
The oligo microarray
Agilent Whole Human Genome Oligo Microarray Kit (G4112F; Agilent) was used to determine the CASZ1-induced transcriptional profiles in SY5Ytet-CASZ1b cells. Gene expression with or without Tet induction (24 h) was analyzed in biological triplicates. The microarray data are available from 19, 20 was performed using the whole gene list generated by uploading the raw microarray data to Partek Genomics Suite 6.6. Intensity values were normalized to the 75th percentile of each array and the genes with intensity values o1 were excluded. A oneway analysis of variance was used to detect differentially expressed genes. This whole gene list was preranked based on fold change, and then uploaded to the GSEA software.
Protein isolation, co-IP and western blot analysis
For assessment of protein levels, cells were lysed 24 h after transfection using RIPA buffer, and 10 μg of total protein was separated and electroblotted as described previously. 14 were used as the primary antibody. Protein bands were detected using a goat anti-mouse or rabbit IgG-HRP-conjugated secondary antibody (Santa Cruz Biotechnology; catalog no. sc-2030 and sc-2031) and visualized using enhanced chemiluminescence (GE Healthcare Life Sciences, Pittsburgh, PA, USA). co-IP was performed as described previously. 16 In brief, human embryonic kidney 293T cells in 10 cm dishes were transiently transfected with empty vector or FLAG-CASZ1b or mutant constructs for 24 h and whole-cell extracts were incubated with Anti-FLAG M2 Magnetic Beads (Sigma-Aldrich; catalog no. M8823) and agitated at 4°C for 4 h. The co-IP products were eluted by incubating with 2x SDS loading buffer and boiling for 3 min. Rabbit anti-HDAC1, RBAP46/48, MBD3 and PARP1 antibody (Cell Signaling Technology; catalog nos. 2062, 4633, 14540 and 9532), anti-MTA3 antibody (Bethyl Laboratories, Montgomery, TX, USA; A300-160 A) and antihistone H3 (Active Motif, Carlsbad, CA, USA; catalog no. 39163) were used as the primary antibody.
Analysis of CASZ1 subcellular localization
Different cell lines were transiently transfected with FLAG-CASZ1a, FLAG-CASZ1b, CASZ1b-EGFP, NLS2-GFP, NES-NLS2-GFP as well as deletion or mutation constructs as described above in 8-well Lab-Tek Chamber Slides from Electron Microscopy Sciences (Hatfield, PA, USA) or regular 12-well plates. To inhibit nuclear export, 20 h after transfection, the transfected cells were treated with 20 ng/ml of LMB for 3.5 h before fixation. Cells were fixed, permeabilized, blocked and stained as described previously. 14 For indirect immunofluorescent cell staining, an anti-FLAG M2 monoclonal antibody (Sigma-Aldrich; catalog no. F1804) and an Alexa Fluor 594-conjugated goat anti-mouse antibody (ThermoFisher Scientific, Walkersville, MD, USA; catalog no. A-11005) were used to detect FLAG-CASZ1b. Adult mouse eye sections and mouse xenograft tumors of human NB cell line that has been stably transfected with Tet-inducible CASZ1 (NGPtetCASZ1) were dissected and stained as following the previously described protocol. 4 A rabbit anti-CASZ1 antibody (1:1000) (made in collaboration with Rockland antibodies and assays, Limerick, PA, USA) was used to detect CASZ1 protein. Localization was analyzed and imaged using a Zeiss LSM 710 confocal microscope (Zeiss, Peabody, MA, USA), a Zeiss microscope ApoTome 2 developed by Zeiss or a Nikon Eclipse TE300 microscope (Melville, NY, USA). To quantify the subcellular localization of NLS2-GFP, NES-NLS2-GFP and NESm-NLS2-GFP, as well as CASZ1bΔ168 treated with or without LMB, 100 cells were counted from each filed, and three fields were counted for each experiment. TMA was performed as reported previously. 52 Cases for the NB TMA were selected from a review of peripheral neuroblastic tumors accessioned to the Pathology Department of the Children's Hospital of Philadelphia from 1987 to 2004. Selection of specimens and construction of the TMA followed after approval by the Children's Hospital of Philadelphia Institutional Review Board. All tumors were reviewed by a pediatric pathologist (BP) for adequacy, and classified pathologically using the INPC (International Neuroblastoma Pathology Classification) criteria. The resultant TMA comprised two paraffin blocks and contained duplicate tumor cores from 187 samples obtained from 167 patients, 20 of who had multiple specimens. Cores (0.6 mm) of representative tumor tissue from each case were used to construct the TMA blocks using a manual arrayer (Beecher Instruments Inc., Sun Prairie, WI, USA). Cores from normal tissues were placed in each of the TMA blocks as controls. Mouse xenograft tumors of human NB cell line that has been stably transfected with Tet-inducible CASZ1 (NGPtetCASZ1) was used as a control to optimize the staining protocol. The TMA was stained with anti-rabbit CASZ1 (Rockland antibodies) at a dilution of 1:1000. Only those samples with consistent results in the duplicates were used for data analysis. χ 2 test was used for TMA data analysis.
Statistical analyses
Statistical analyses of the TMA data were performed using χ 2 test, with Po0.05 considered significant. Statistical analyses of other data were performed using t-test, with Po0.05 considered significant. The statistical tests were two-sided. IPA of microarray data was analyzed by Fisher's exact test (http://www.ingenuity.com/). Kolmogorov-Smirnov statistic was used by GSEA for the microarray data analysis. Values in the graphs are expressed as means ± s.e.m. or means ± s.d. from technical triplicates, and the data presented are the representative results from one of the two or three reproducible biological replicates.
